Maarten Cozijnsen

Addenda Summary Samenvatting Co-authors’ affiliations About the author Dankwoord P155 P159 P165 P169 P175 Chapter 7 General discussion P139 Chapter 6 The benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease Inflamm Bowel Dis. 2015 Apr;21(4):951-61. P113 Chapter 5 Adalimumab therapy in children with Crohn’s disease previously treated with infliximab J Pediatr Gastroenterol Nutr. 2015 Feb;60(2):205-10. P95